Id	Study	Session	StudySession	SL	TL	Task	Text	Part	SGroup	TGroup	STid	SGid	STseg	TokS	LenS	TTid	TGid	TTseg	TokT	LenT	Ins	Del	Munit	InEff	FixS	TrtS	OrtS	OrtT	MU1rtS	MU1rtT	FFTimeS	FFDurS	FixT	TrtT	FFTimeT	FFDurT	CrossS	CrossT	Pause	Dur	End	Edit	Pause1	Time1	Ins1	Del1	Dur1	End1	Edit1	Pause2	Time2	Ins2	Del2	Dur2	End2	Edit2	PauseR	TimeR	InsR	DelR	DurR	EditR	Edit
1	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	How	Wie	1	1	1	1	3	1	1	1	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
2	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	does_work	wirkt	2	2+4	1	2	8	2	2	1	1	9	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	72915	2918	75833	wirkt_	72915	72915	6	0	640	73555	wirkt_[	0	0	0	0	0	0	---	0	0	0	0	0	---	wirkt_
3	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	3	3	1	1	8	3	3	1	1	8	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	624	24726	102680	_	624	77954	0	1	0	77954	_]	0	0	0	0	0	0	---	0	0	0	0	0	---	_
4	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	?	?	5	5	1	1	1	4	4	1	1	1	0	22	1	-1.0952	0	0	0	0	0	0	0	0	0	0	0	0	1	2	2278	2121	77954	[zu_arbeiten	2278	75833	0	11	1497	77330	zu_arbeiten	0	0	0	0	0	0	---	0	0	0	0	0	---	[zu_arbeiten
5	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	The	Der	6	6	2	1	3	5	5	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
6	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	active_substance	Wirkstoff	7	7+8	2	2	15	6	6	2	1	16	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
7	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	in	in	9	9	2	1	2	7	7	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
8	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	10	10	2	1	8	8	8	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
9	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	11	11	2	1	1	9	9	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
10	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	topotecan	Topotecan	12	12	2	1	9	10	10	2	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
11	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	13	13	2	1	1	11	11	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
12	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	is	ist	14	14	2	1	2	12	12	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
13	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	an	ein	15	15	2	1	2	13	13	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
14	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	anticancer	gegen_Krebs	16	16	2	1	10	15	15+16	2	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
15	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	medicine	Arzneimittel	17	17	2	1	8	14	14	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
16	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	that	,_das	18	18	2	1	4	17	17+18	2	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
17	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	belongs	gehört	19	19	2	1	7	27	27	2	1	7	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	1528	968	105832	[gehört	1528	104864	6	0	656	105520	gehört	0	0	0	0	0	0	---	0	0	0	0	0	---	[gehört
18	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	to_the	zur	20	20+21	2	2	5	19	19	2	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-8	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
19	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	group	Gruppe	22	22	2	1	5	20	20	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
20	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	""""	""""	23	23	2	1	1	22	22	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
21	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	topoisomerase	Topoisomerase_-	24	24	2	1	13	23	23+24	2	2	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
22	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	inhibitors	Hemmer	25	25	2	1	10	25	25	2	1	10	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	24726	2184	104864	[_[_	24726	102680	1	1	656	103336	_[_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[_[_
23	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	26	26	2	1	1	28	28	2	1	1	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	312	15054	120886	.	312	105832	1	0	0	105832	.[	0	0	0	0	0	0	---	0	0	0	0	0	---	.
24	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	It	Es	28	28	3	1	2	29	29	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
25	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	blocks	blockiert	29	29	3	1	6	30	30	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
26	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	an	das	30	30	3	1	2	31	31	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
27	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	enzyme	Enzym	31	31	3	1	6	32	32	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
28	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	topoisomerase	Topoisomerase	33	33	3	1	13	33	33	3	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
29	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	I	I	34	34	3	1	1	34	34	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
30	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	35	35	3	1	1	35	35	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
31	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	which	das	36	36	3	1	5	36	36	3	1	5	4	4	1	9.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	15054	5132	126018	[ei]as	15054	120886	2	2	514	121400	ei]as[	0	0	0	0	0	0	---	0	0	0	0	0	---	[ei]as
32	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	is	ist	37	37	3	1	2	43	43	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
33	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	involved	beteiligt	38	38	3	1	8	42	42	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
34	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	in	an	39	39	3	1	2	37	37	3	1	2	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	4618	32870	158888	[i]a	4618	126018	1	1	1123	127141	i]a	0	0	0	0	0	0	---	0	0	0	0	0	---	[i]a
35	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	der	40	40	3	1	3	38	38	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
36	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	division	Teilung	41	41	3	1	8	39	39	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
37	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	of	der	42	42	3	1	2	40	40	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
38	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	DNA	DNA	43	43	3	1	3	41	41	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
39	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	44	44	3	1	1	44	44	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
40	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	---	27	119	3	1	1	0	0	0	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	75	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
41	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	---	32	119	3	1	1	0	0	0	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
42	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	When	Wenn	45	45	4	1	4	45	45	4	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	-74	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
43	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	das	46	46	4	1	3	46	46	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
44	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	enzyme	Enzym	47	47	4	1	6	47	47	4	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
45	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	is	ist	48	48	4	1	2	49	49	4	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
46	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	blocked	blockiert	49	49	4	1	7	48	48	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
47	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	50	50	4	1	1	50	50	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
48	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	die	51	51	4	1	3	52	52	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
49	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	DNA	DNA_-	52	52	4	1	3	53	53+54	4	2	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
50	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	strands	Stränge	53	53	4	1	7	55	55	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
51	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	break	brechen	54	54	4	1	5	51	51	4	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
52	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	55	55	4	1	1	56	56	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
53	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	This	Dies	56	56	5	1	4	57	57	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
54	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	prevents	verhindert	57	57	5	1	8	58	58	5	1	8	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	31747	1138	160026	_	31747	158888	1	0	0	158888	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
55	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	der	58	58	5	1	3	61	61	5	1	3	4	4	1	9.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	2418	8330	174238	ie]er	2418	165908	2	2	764	166672	ie]er[	0	0	0	0	0	0	---	0	0	0	0	0	---	ie]er
56	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	cancer_cells	Krebszellen	59	59+60	5	2	11	62	62	5	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
57	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	from	die	61	61	5	1	4	59	59	5	1	4	8	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	1138	531	160557	die_	1138	160026	4	0	344	160370	die_	0	0	0	0	0	0	---	0	0	0	0	0	---	die_
58	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	dividing	Teilung	62	62	5	1	8	60	60	5	1	8	14	12	1	9.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	187	5351	165908	Teilung[,_dass	187	160557	7	6	2933	163490	Teilung[,_dass	0	0	0	0	0	0	---	0	0	0	0	0	---	Teilung[,_dass
59	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	and	,_sodass	63	63	5	1	3	63	63+64	5	2	2	18	42	1	-2.6522	0	0	0	0	0	0	0	0	0	0	0	0	4	1	7566	24477	198715	[_an_der_T]_[eilung,_und],_sodass[_	7566	174238	9	21	8564	182802	_an_der_T]_[eilung,_und],_sodass[_	0	0	0	0	0	0	---	0	0	0	0	0	---	[_an_der_T]_[eilung,_und],_sodass[_
60	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	they	sie	64	64	5	1	4	65	65	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
61	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	eventually	schließlich	65	65	5	1	10	66	66	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
62	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	die	sterben	66	66	5	1	3	67	67	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
63	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	67	67	5	1	1	68	68	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
64	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	68	68	6	1	8	69	69	6	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
65	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	also	auch	69	69	6	1	4	72	72	6	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
66	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	affects	wirkt_sich_auf_aus	70	70	6	1	7	70	70+71+73+77	6	4	4	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	780	8035	223176	aus	780	215141	3	0	172	215313	aus[	0	0	0	0	0	0	---	0	0	0	0	0	---	aus
67	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	non	Nicht	71	71	6	1	3	74	74	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
68	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	-	-	72	72	6	1	1	75	75	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
69	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	cancer_cells	Krebszellen	73	73+74	6	2	11	76	76	6	1	12	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	15241	780	215141	_	15241	214361	1	0	0	214361	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
70	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	75	75	6	1	1	78	78	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
71	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	which	was	76	76	6	1	5	79	79	6	1	5	6	6	1	13.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	42869	4790	539468	[die]was	0	0	0	0	0	0	---	0	0	0	0	0	0	---	42869	534678	3	3	1170	die]was[	[die]was
72	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	causes	verursacht	77	77	6	1	6	81	81	6	1	6	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	250	0	539842	[t	0	0	0	0	0	0	---	0	0	0	0	0	0	---	250	539842	1	0	0	t	[t
73	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	side_effects	Nebenwirkungen	78	78+79	6	2	11	80	80	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
74	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	80	80	6	1	1	82	82	6	1	1	4	6	2	-11.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	19533	16020	539842	t]en[en	15913	198715	2	1	405	199120	t]en	0	0	0	0	0	0	---	3620	539468	0	2	124	en]	t]en[en
75	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	How	Wie	81	81	7	1	3	83	83	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
76	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	has_been	wurde	82	82+84	7	2	7	84	84	7	1	8	10	6	1	3.4000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	7863	9640	232816	[hat]wurde	7863	223176	5	3	1528	224704	hat]wurde[	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat]wurde
77	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	83	83	7	1	8	85	85	7	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
78	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	studied	untersucht	85	85	7	1	7	86	86	7	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
79	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	?	?	86	86	7	1	1	87	87	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
80	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	87	87	8	1	8	88	88	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
81	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	as	als	88	88	8	1	2	89	89	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
82	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	infusion	Infusion	90	90	8	1	8	90	90	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
83	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	has	ist	91	91	8	1	3	91	91	8	1	3	4	4	1	9.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	10623	22558	321737	ha]is	10623	299179	2	2	593	299772	ha]is	0	0	0	0	0	0	---	0	0	0	0	0	---	ha]is
84	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	been	worden	92	92	8	1	4	113	113	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	22	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
85	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	studied	untersucht	93	93	8	1	7	112	112	8	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
86	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	in	bei	94	94	8	1	2	92	92	8	1	2	6	4	1	3.6667	0	0	0	0	0	0	0	0	0	0	0	0	-20	1	8112	6724	239540	[in]bei	8112	232816	3	2	1077	233893	in]bei[	0	0	0	0	0	0	---	0	0	0	0	0	---	[in]bei
87	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	more	mehr	95	95	8	1	4	93	93	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
88	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	than	als	96	96	8	1	4	94	94	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
89	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	480	480	97	97	8	1	3	95	95	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
90	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	women	Frauen	98	98	8	1	5	96	96	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
91	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	with	mit	99	99	8	1	4	97	97	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
92	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	ovarian_cancer	Eierstockkrebs	100	100+101	8	2	13	98	98	8	1	14	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
93	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	who	,_bei_denen	102	102	8	1	3	99	99+100+101	8	3	1	18	8	1	2.4545	0	0	0	0	0	0	0	0	0	0	0	0	3	1	5647	49016	288556	[_]bei_[ie]enn[n]en	5647	239540	9	4	26489	266029	_]bei_[ie]enn[n]en[	0	0	0	0	0	0	---	0	0	0	0	0	---	[_]bei_[ie]enn[n]en
94	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	had	war	103	103	8	1	3	110	110	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
95	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	failed	gescheitert	104	104	8	1	6	109	109	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
96	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	one	eine	105	105	8	1	3	102	102	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
97	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	treatment	Behandlung	106	106	8	1	9	103	103	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
98	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	with	mit	107	107	8	1	4	104	104	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
99	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	platinum_-_containing	platinhaltigen	108	108+109+110	8	3	19	105	105	8	1	21	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
100	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	anticancer	gegen_Krebs	111	111	8	1	10	107	107+108	8	2	9	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	22527	10623	299179	[,	22527	288556	0	1	0	288556	,	0	0	0	0	0	0	---	0	0	0	0	0	---	[,
101	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	medicines	Arzneimitteln	112	112	8	1	9	106	106	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
102	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	113	113	8	1	1	114	114	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	8	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
103	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	---	89	119	8	1	1	0	0	0	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	6	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
104	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Three	Drei	114	114	9	1	5	115	115	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	0	-5	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
105	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	studies	Studien	115	115	9	1	7	116	116	9	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
106	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	were	waren	116	116	9	1	4	117	117	9	1	4	10	10	1	21.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	6209	31403	365573	sei]wawr[rw]r	6209	334170	5	5	3042	337212	sei]wawr[rw]r	0	0	0	0	0	0	---	0	0	0	0	0	---	sei]wawr[rw]r
107	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	""""	""""	117	117	9	1	1	118	118	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
108	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	open	offen	118	118	9	1	4	119	119	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
109	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	""""	""""	120	120	9	1	1	120	120	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
110	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	meaning	,_was_bedeutet	121	121	9	1	7	121	121+122+123	9	3	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
111	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	that	,_dass	122	122	9	1	4	124	124+125	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
112	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	das	123	123	9	1	3	126	126	9	1	3	4	4	1	9.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	33696	3339	402608	[ei]as	33696	399269	2	2	780	400049	ei]as[	0	0	0	0	0	0	---	0	0	0	0	0	---	[ei]as
113	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	medicine	Medikament	124	124	9	1	8	127	127	9	1	8	14	8	1	3.2857	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2559	24788	427396	[nizi]ikament	2559	402608	7	4	2199	404807	nizi]ikament	0	0	0	0	0	0	---	0	0	0	0	0	---	[nizi]ikament
114	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	was	werden_kann	125	125	9	1	3	134	134+135	9	2	2	22	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	8	1	5148	22137	454681	werden_kann	5148	432544	11	0	1872	434416	werden_kann[	0	0	0	0	0	0	---	0	0	0	0	0	---	werden_kann
115	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	not	nicht	126	126	9	1	3	128	128	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
116	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	compared	verglichen	127	127	9	1	8	133	133	9	1	8	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	22589	5148	432544	_	22589	427396	1	0	0	427396	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
117	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	to	mit	128	128	9	1	2	129	129	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
118	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	any	einer	129	129	9	1	3	130	130	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
119	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	other	anderen	130	130	9	1	5	131	131	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
120	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	treatment	Behandlung	131	131	9	1	9	132	132	9	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
121	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	and	und	132	132	9	1	3	137	137	9	1	3	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	28361	33696	399269	_	28361	365573	1	0	0	365573	_[	0	0	0	0	0	0	---	0	0	0	0	0	---	_
122	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	die	133	133	9	1	3	139	139	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
123	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	patients	Patienten	134	134	9	1	8	140	140	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
124	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	knew	wussten	135	135	9	1	4	141	141	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
125	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	that	,_dass	136	136	9	1	4	142	142+143	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
126	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	they	sie	137	137	9	1	4	144	144	9	1	4	0	20	1	-1.1053	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2231	7597	334170	[netleihre_	2231	326573	0	10	1388	327961	netleihre_	0	0	0	0	0	0	---	0	0	0	0	0	---	[netleihre_
127	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	were_receiving	erhielten	138	138+139	9	2	13	146	146	9	1	14	18	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	562	4274	326573	erhielten	562	322299	9	0	2043	324342	erhielten[	0	0	0	0	0	0	---	0	0	0	0	0	---	erhielten
128	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	140	140	9	1	8	145	145	9	1	8	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	21965	562	322299	_	21965	321737	1	0	0	321737	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
129	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	141	141	9	1	1	147	147	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
130	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	The	Die	142	142	10	1	3	148	148	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
131	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	fourth	vierte	143	143	10	1	6	149	149	10	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
132	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	study	Studie	144	144	10	1	5	150	150	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
133	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	involved	umfasste	145	145	10	1	8	151	151	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
134	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	226	226	146	146	10	1	3	152	152	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
135	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	women	Frauen	147	147	10	1	5	153	153	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
136	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	,	,	148	148	10	1	1	154	154	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
137	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	and	bei_der	149	149	10	1	3	155	155+156	10	2	2	14	6	1	2.3333	0	0	0	0	0	0	0	0	0	0	0	0	2	1	20265	10483	465164	[und]bei_der	20265	454681	7	3	5320	460001	und]bei_der	0	0	0	0	0	0	---	0	0	0	0	0	---	[und]bei_der
138	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	compared	verglichen_wurde	150	150	10	1	8	167	167+168	10	2	7	32	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	12	1	375	4633	470172	verglichen_wurde	375	465539	16	0	1872	467411	verglichen_wurde[	0	0	0	0	0	0	---	0	0	0	0	0	---	verglichen_wurde
139	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	Hycamtin	Hycamtin	151	151	10	1	8	157	157	10	1	8	0	22	1	-1.0952	0	0	0	0	0	0	0	0	0	0	0	0	-11	1	2761	20576	490748	[verglichen_	2761	470172	0	11	1747	471919	verglichen_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[verglichen_
140	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	with	mit	152	152	10	1	4	158	158	10	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
141	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	paclitaxel	Paclitaxel	153	153	10	1	10	159	159	10	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
142	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	(	(	154	154	10	1	1	160	160	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
143	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	another	ein_anderes	155	155	10	1	7	161	161+162	10	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
144	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	anticancer	gegen_Krebs	156	156	10	1	10	164	164+165	10	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
145	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	medicine	Arzneimittel	157	157	10	1	8	163	163	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
146	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	)	)	158	158	10	1	1	166	166	10	1	1	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	5163	375	465539	_	5163	465164	1	0	0	465164	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
147	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	159	159	10	1	1	169	169	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
148	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	The	Der	160	160	11	1	3	170	170	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
149	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	main_measure	Hauptindikator	161	161+162	11	2	11	171	171	11	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
150	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	of	für_die	163	163	11	1	2	172	172+173	11	2	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
151	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	effectiveness	Wirksamkeit	164	164	11	1	13	174	174	11	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
152	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	was	war	165	165	11	1	3	175	175	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
153	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	the	die	166	166	11	1	3	176	176	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
154	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	number	Anzahl	167	167	11	1	6	177	177	11	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
155	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	of	der	168	168	11	1	2	178	178	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
156	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	patients	Patienten	169	169	11	1	8	179	179	11	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
157	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	whose	,_deren	170	170	11	1	5	180	180+181	11	2	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
158	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	tumours	Tumoren	171	171	11	1	7	182	182	11	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
159	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	responded	ansprachen	172	172	11	1	9	186	186	11	1	9	16	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	18829	43930	534678	[sprachen	18829	490748	8	0	1061	491809	sprachen[	0	0	0	0	0	0	---	0	0	0	0	0	---	[sprachen
160	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	to	auf	173	173	11	1	2	183	183	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
161	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	treatment	Behandlung	174	174	11	1	9	185	185	11	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
162	OCT13	P20_PL03	OCT13@P20_PL03	en	de	PL	03	P20	.	.	175	175	11	1	1	187	187	11	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---